InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program
Marijuana Stocks, Finance, & Investing March 17, 2019 MJ Shareholders 0
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program " />
Planet 13 Holdings Inc. (CSE: PLTH) (OTCQB: PLNHF), a leading vertically-integrated Nevada cannabis company, announced today that it has signed a Purchase Agreement with Mike Tyson’s cannabis venture, Tyson Ranchk, to be the exclusive launch partner of Tyson Ranch products in Nevada.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.